BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16704696)

  • 61. Influence of test reliability on the screening performance of frequency-doubling perimetry.
    Heeg GP; Jansonius NM
    Am J Ophthalmol; 2006 Mar; 141(3):585-7. PubMed ID: 16490521
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The value of frequency doubling perimetry in glaucoma screening of aged 40 or more population].
    Li JJ; Xu L; Zhang RX; Sun XY; Yang H; Zou Y; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2005 Mar; 41(3):221-5. PubMed ID: 15840362
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Visual function-specific perimetry to identify glaucomatous visual loss using three different definitions of visual field abnormality.
    Tafreshi A; Sample PA; Liebmann JM; Girkin CA; Zangwill LM; Weinreb RN; Lalezary M; Racette L
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1234-40. PubMed ID: 18978349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detecting visual function abnormalities using the Swedish interactive threshold algorithm and matrix perimetry in eyes with glaucomatous appearance of the optic disc.
    Sakata LM; Deleon-Ortega J; Arthur SN; Monheit BE; Girkin CA
    Arch Ophthalmol; 2007 Mar; 125(3):340-5. PubMed ID: 17353404
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Strategies for improving the diagnostic specificity of the frequency doubling perimeter.
    Heeg GP; Stoutenbeek R; Jansonius NM
    Acta Ophthalmol Scand; 2005 Feb; 83(1):53-6. PubMed ID: 15715557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined use of frequency doubling perimetry and polarimetric measurements of retinal nerve fiber layer in glaucoma detection.
    Horn FK; Nguyen NX; Mardin CY; Jünemann AG
    Am J Ophthalmol; 2003 Feb; 135(2):160-8. PubMed ID: 12566019
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Performance of community-based glaucoma screening using Frequency Doubling Technology and Heidelberg Retinal Tomography.
    Robin TA; Müller A; Rait J; Keeffe JE; Taylor HR; Mukesh BN
    Ophthalmic Epidemiol; 2005 Jun; 12(3):167-78. PubMed ID: 16036475
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Localized retinal nerve fiber layer defects and visual field abnormalities by humphrey matrix frequency doubling technology perimetry.
    Lee MJ; Kim DM; Jeoung JW; Hwang SS; Kim TW; Park KH
    Am J Ophthalmol; 2007 Jun; 143(6):1056-8. PubMed ID: 17524781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study.
    Sample PA; Medeiros FA; Racette L; Pascual JP; Boden C; Zangwill LM; Bowd C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3381-9. PubMed ID: 16877406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frequency-doubling threshold perimetry in predicting glaucoma in a population-based study: The Beijing Eye Study.
    Wang YX; Xu L; Zhang RX; Jonas JB
    Arch Ophthalmol; 2007 Oct; 125(10):1402-6. PubMed ID: 17923550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Frequency doubling perimetry in diagnosis of early glaucomatous optic nerve fiber damage].
    Korzekwa W; Korzekwa M; Markowska J; Wójcik-Niklewska B; Romaniuk W; Korzekwa A; Michalska-Małecka K
    Klin Oczna; 2004; 106(1-2 Suppl):222-4. PubMed ID: 15510506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of decision rules for frequency-doubling technology screening tests.
    Gardiner SK; Anderson DR; Fingeret M; McSoley JJ; Johnson CA
    Optom Vis Sci; 2006 Jul; 83(7):432-7. PubMed ID: 16840859
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term reproducibility of screening for glaucoma with FDT-perimetry.
    Horn FK; Link B; Mardin CY; Jünemann AG; Martus P
    J Glaucoma; 2007 Aug; 16(5):448-55. PubMed ID: 17700287
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term fluctuation of standard automatic perimetry, pulsar perimetry and frequency-doubling technology in early glaucoma diagnosis.
    Gonzalez-Hernandez M; de la Rosa MG; de la Vega RR; Hernandez-Vidal A
    Ophthalmic Res; 2007; 39(6):338-43. PubMed ID: 17952009
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Topographic relationship between frequency-doubling technology threshold values.
    Fuertes-Lazaro I; Sanchez-Cano A; Ferreras A; Larrosa JM; Garcia-Martin E; Pablo LE
    Acta Ophthalmol; 2012 Mar; 90(2):e144-50. PubMed ID: 22103468
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma.
    Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
    Ophthalmology; 2008 Apr; 115(4):667-72. PubMed ID: 17716733
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Humphrey Matrix perimetry in optic nerve and chiasmal disorders: comparison with Humphrey SITA standard 24-2.
    Huang CQ; Carolan J; Redline D; Taravati P; Woodward KR; Johnson CA; Wall M; Keltner JL
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):917-23. PubMed ID: 18326712
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Learning effect among perimetric novices with screening C-20-1 frequency doubling technology perimetry.
    Brush MB; Chen PP
    Am J Ophthalmol; 2004 Mar; 137(3):551-2. PubMed ID: 15013879
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The reliability of frequency-doubling technology (FDT) perimetry in a pediatric population.
    Becker K; Semes L
    Optometry; 2003 Mar; 74(3):173-9. PubMed ID: 12645850
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Learning effect of humphrey matrix frequency doubling technology perimetry in patients with ocular hypertension.
    Centofanti M; Fogagnolo P; Oddone F; Orzalesi N; Vetrugno M; Manni G; Rossetti L
    J Glaucoma; 2008 Sep; 17(6):436-41. PubMed ID: 18794676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.